Inactive Instrument

News NICOX Swiss Exchange

Stocks

OXCOX

FR0000074130

Pharmaceuticals

All News

09-16	Nicox to present NCX 470 data at a conference
09-16	Data on Nicox's NCX 470 to be presented at AAOpt Annual Meeting 2026	GL
09-11	Chinese Regulator Accepts Nicox's Glaucoma Drug Application for Review	MT
09-11	Nicox S.A. Announces Acceptance Of NCX 470 NDA For Review In China	CI
09-11	Nicox wins regulatory acceptance in China
09-11	Nicox Announces NCX 470 NDA in China Accepted for Review	GL
09-02	Nicox Announces Extension of Cash Runway	GL
09-02	Nicox S.A. Announces Appointment of Doug Hubatsch as Chief Scientific Advisor	CI
08-27	The FDA will issue its decision on Nicox's NCX 470 by the end of next April
08-27	US FDA to Complete Nicox's Glaucoma Drug Review by April 2027	MT
08-27	Nicox Announces April 2027 PDUFA Date for NCX 470 in Glaucoma	GL
08-27	Nicox S.A. Announces U.S. Food and Drug Administration Accepts the New Drug Application for NCX 470	CI
08-10	Nicox Partner Files China Drug Application for NCX 470 Eye Drop	MT
08-10	A Nicox partner has cleared an important milestone in China
08-10	Nicox Announces NCX 470 NDA Submission in China by Partner Ocumension	GL
07-01	Nicox Submits NCX 470 New Drug Application In The United States	CI
07-01	Nicox files U.S. marketing approval application
07-01	Nicox’s NCX 470 New Drug Application Submitted in the United States by Kowa, with Associated €3 million Milestone Payment	GL
06-23	Nicox Bags EUR6 Million Shareholder Loan	MT
06-23	Nicox Secures Backing From a Shareholder and Financial Partner
06-23	Nicox and Vester Finance Sign Shareholder Loan Agreement to Support Strategic Activities for the Company	GL
06-18	Nicox Receives Positive Feedback from China
06-18	Nicox Announces Positive Pre-Submission Regulatory Feedback in China Supporting NDA Filing for NCX 470	CI
06-18	Nicox Announces Positive Pre-submission Regulatory Feedback in China Supporting NDA filing for NCX 470	GL
06-08	Reminder: Nicox June 2024 Warrants will expire June 19, 2026	GL